The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 3 Regulatory News (DNA3)

Share Price Information for Doric Nimrod 3 (DNA3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.00
Bid: 50.00
Ask: 52.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.00%)
Open: 51.00
High: 51.50
Low: 51.00
Prev. Close: 51.00
DNA3 Live PriceLast checked at -
Doric Nimrod Air Three is an Investment Trust

To obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Aircraft

14 Nov 2013 17:15

RNS Number : 0873T
Doric Nimrod Air Three Limited
14 November 2013
 



NOT FOR DISTRIBUTION OR RELEASE IN ANY JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

DORIC NIMROD AIR THREE LIMITED

DNA ALPHA LIMITED

Acquisition of the third aircraft

14 November 2013

 

Doric Nimrod Air Three Limited ("DNA3") and its wholly-owned subsidiary DNA Alpha Limited ("DNA Alpha") are pleased to announce that DNA Alpha, on 14 November 2013 purchased an Airbus A380-861 aircraft bearing manufacturer's serial number 134 (the "Aircraft") for the sum of US$245,000,000.

 

DNA Alpha also entered into an Aircraft Operating Lease Agreement with Emirates pursuant to which the Aircraft would be leased to Emirates.

 

This Aircraft is the third acquired by the Company, the first having been delivered in August 2013 and the second in October 2013. The remaining Airbus A380 aircraft to be acquired pursuant to the Initial Investment Process outlined in the DNA3 Prospectus dated 20 June 2013 is anticipated to be purchased by the end of 2013.

 

About the Company

DNA3 is a Guernsey domiciled company with shares admitted to the official list of the Channel Islands Stock Exchange and to trading on the Specialist Fund Market of the London Stock Exchange (LSE:DNA3).

DNA Alpha is a Guernsey domiciled company with pass through certificates admitted to listing on the Official List and trading on the Main Securities Market of the Irish Stock Exchange.

DNA3's investment objective is to obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft (the "Assets").

To pursue its investment objective, DNA3 will seek to use the net proceeds of placings and other equity capital raisings, together with debt facilities (or instruments), to initially acquire Airbus A380 aircraft which will be leased to one or more major airlines.

The Company aims to provide Shareholders with an attractive total return comprising income, from distributions through the period of the Company's ownership of the Assets, and capital, upon the sale of the Assets.

 

For further information, please contact:

For administrative and company information:

Anson Fund Managers Limited

+44 (0) 1481 722260

 

 For shareholder information:

Nimrod Capital LLP

Richard Bolchover

Marc Gordon

+44 (0) 20 3355 6855

 

E&OE - In Transmission

 

END OF ANNOUNCEMENT

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUSANROBAAAAA
Date   Source Headline
11th Apr 20245:06 pmRNSQuarterly Factsheet
11th Apr 20245:05 pmRNSDividend Declaration
28th Mar 20249:22 amRNSMSN 133 REDELIVERY CONDITION
15th Mar 20249:24 amRNSMSN 134 REDELIVERY CONDITION
4th Mar 202412:46 pmRNSMSN 136 REDELIVERY CONDITION
11th Jan 20244:21 pmRNSQuarterly Report
11th Jan 20244:19 pmRNSDividend Declaration
4th Jan 20244:07 pmRNSMSN132 REDELIVERY CONDITION
15th Dec 20232:45 pmRNSUnaudited Interim Financial Report
8th Dec 20237:00 amRNSResult of AGM
13th Nov 20233:47 pmRNSNotice of AGM
10th Oct 20234:45 pmRNSQuarterly Report
10th Oct 20234:44 pmRNSDividend Declaration
31st Jul 20234:19 pmRNSResignation of a non-executive director
24th Jul 20235:43 pmRNSAnnual Financial Report
13th Jul 20234:59 pmRNSQuarterly Report
13th Jul 20234:58 pmRNSDividend Declaration
18th Apr 20237:00 amRNSDirectorate Change
13th Apr 20235:04 pmRNSDividend Declaration
13th Apr 20235:04 pmRNSQuarterly Report
4th Apr 20237:00 amRNSDirectorate Change
15th Feb 20237:00 amRNSChange in Board and Board Committee Composition
13th Jan 20234:58 pmRNSQuarterly Report
12th Jan 20235:26 pmRNSDividend Declaration
15th Dec 20225:25 pmRNSHalf-year Report
13th Dec 20229:34 amRNSDirector Declaration
12th Dec 202212:09 pmRNSResult of AGM
15th Nov 20224:45 pmRNSNotice of AGM
13th Oct 20225:21 pmRNSQuarterly Report
13th Oct 20225:19 pmRNSDividend Declaration
23rd Sep 20223:10 pmRNSHolding(s) in Company
22nd Sep 20224:32 pmRNSHolding(s) in Company
8th Aug 20225:12 pmRNSHolding(s) in Company
29th Jul 20226:26 pmRNSAnnual Financial Report
15th Jul 20223:27 pmRNSQuarterly Report
14th Jul 20224:26 pmRNSDividend Declaration
12th Apr 20224:58 pmRNSQuarterly Report
12th Apr 20224:49 pmRNSDividend Declaration
1st Mar 20222:34 pmRNSDirectorate Change
13th Jan 20225:05 pmRNSQuarterly Report
13th Jan 20225:05 pmRNSDividend Declaration
21st Dec 202112:55 pmRNSDirectorate Change
16th Dec 20215:03 pmRNSHalf-year Report
9th Dec 20216:05 pmRNSResult of AGM
27th Oct 20211:14 pmRNSNotice of AGM
14th Oct 20214:00 pmRNSQuarterly Report
14th Oct 20214:00 pmRNSDividend Declaration
1st Oct 20217:00 amRNSHolding(s) in Company
12th Aug 20215:30 pmRNSAnnual Financial Report - Correction
2nd Aug 20216:34 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.